Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 360 (9344) , 1478-1480
- https://doi.org/10.1016/s0140-6736(02)11437-1
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- A frameshift mutation in NOD2 associated with susceptibility to Crohn's diseaseNature, 2001
- Is Crohn's Disease an Immunodeficiency?Digestive Diseases and Sciences, 2000
- Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel diseaseGastroenterology, 1994
- Development of a Crohn's Disease Activity IndexGastroenterology, 1976